DB
Double Blind Bio Inc.
SEC filingOther Technology · San Francisco, CA
Amount raised$5.6Msold at filing
Total offering$5.6M
Investors in the raise6count reported to the SEC
FiledDec 29, 2025first sale Dec 10, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
David HughesExecutive Officer, Director
Shruti TibrewalaExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.